Caris Life Sciences
Outcome
OIG enforcement action against Caris Life Sciences for false claims. Penalty: $2.9 million.
Details
Caris Life Sciences — OIG Enforcement (2026)
OIG took enforcement action against Caris Life Sciences in 2026 involving false claims violations in the Clinical Laboratories sector.
Penalty: $2.9 million
Violation types: False Claims
Entity type: Clinical Laboratory
Penalty type: Settlement
Source: Caris Life Sciences Pays over $2.8 Million to Settle False Claims Act Allegations from Delay in Submission of Genetic Cancer Screening Tests
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works